Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 11, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • COVID-19
  • Page 19

Tag: COVID-19

  • BiotechToday
  • World

Is transmission of SARS-CoV-2 infection from mother to child possible during pregnancy?

bioxone October 13, 2020October 13, 2020

Anuska Sen, Team bioXone It is well known that the SARS-CoV-2 (Covid-19) infection is transmitted by droplets and there have been recent studies showing that it can also be an airborne infection. However, there remains a huge confusion as to whether transmission of SARS-CoV-2 infection is possible from mother to child during pregnancy. This kind […]

Read More
  • BiotechToday
  • World

High dose of Favipiravir helps prevent SARS-CoV-2 infection in hamsters whereas Hydroxychloroquine fails

bioxone October 13, 2020October 12, 2020

Soumya Sarathi Ganguly, Indian Institute of Technology, Kharagpur Virologists were working on two areas of SARS-CoV-2 research at KU Leuven Rega Institute. In one line developing a vaccine that can prevent infection, and in another line of research, they are thriving in search of existing drugs by which the amount of virus can be reduced […]

Read More
  • BiotechToday
  • India
  • World

AstraZeneca: Late-stage trial of Covid-19 antibody medicine to start soon

bioxone October 12, 2020October 12, 2020

Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]

Read More
  • BiotechToday
  • India

Coronavirus | Government to map out cold storage facilities for COVID-19 vaccine delivery

bioxone October 11, 2020October 11, 2020 2

-Sagnik Nag, Amity University With the increasing cases of COVID fever, there’s still hope for upcoming vaccines within a few months. The hope came with a massive responsibility on the Government for mapping out its extensive cold storage to ensure the quick delivery of the vaccine across the country. A national expert group surveyed to […]

Read More
  • BiotechToday
  • World

CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

bioxone October 11, 2020October 10, 2020

-Surupa Chakraborty, Amity University Kolkata A new CRISPR based test that can diagnose the coronavirus infection within few minutes, joins the race of speedy detection after RT-PCR, rapid testing, and FELUDA test. The potent applications of CRISPR have been talked about for many years now. It is best known for its ability to seek out […]

Read More
  • BiotechToday
  • World

Convalescent Plasma Therapy – Promising need of the Hour!

bioxone October 10, 2020October 10, 2020

-Raddur Samaddar, Team bioXone While the world is waiting for a COVID-19 vaccine with absolute eagerness, the closest promising immunological treatment that can help stop the rate of the ever-increasing spread of the SARS-CoV-2 virus is the Convalescent Plasma Therapy. This treatment relies upon the transfusion of the anti-viral antibodies from donors to recipients with […]

Read More
  • BiotechToday
  • India
  • World

Can mutation make you lose your sense of smell?

bioxone October 10, 2020October 10, 2020 10

-Husna, Amity University Kolkata The loss in sense of smell and taste experienced most commonly due to viral fever is termed as Anosmia. Millions of olfactory receptor cells are present in our nasal cavity. These cells captures molecules with specific odour and activate a nerve response which then carries the signal to the brain where […]

Read More
  • BiotechToday
  • World

Take care of the Aged – Dementia in the UK

bioxone October 8, 2020October 8, 2020

Rohit Bhattacharjee, Amity University Kolkata Dementia is a pandemic in the ageing society, the likelihood doubles every five years. People with dementia in the UK, both those living with families or alone, have lost invaluable support. Family carers have lost respite opportunities because of COVID-19, causing them to feel abandoned. The burden of care was […]

Read More
  • BiotechToday
  • World

Appendicitis – Antibiotics or Appendectomy?

bioxone October 7, 2020October 7, 2020

Thota Kanishka Rao, Amity University Kolkata Appendectomy has for quite some time been the standard treatment for appendicitis, even though effective utilisation of anti-microbial therapy as an option was accounted for over 60 years. Even in recent years, more than 95% of U.S. patients with appendicitis underwent an appendectomy. However, with the ongoing Covid-19 pandemic, […]

Read More
  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Read More

Posts navigation

1 … 15 16 17 18 19 20 21 22

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy